BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 19882781)

  • 21. Lacosamide for the treatment of partial-onset seizures.
    Biton V
    Expert Rev Neurother; 2012 Jun; 12(6):645-55. PubMed ID: 22650166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lacosamide-induced valproic acid toxicity.
    Jones GL; Popli GS; Silvia MT
    Pediatr Neurol; 2013 Apr; 48(4):308-10. PubMed ID: 23498565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lacosamide cardiac safety: clinical trials in patients with partial-onset seizures.
    Rudd GD; Haverkamp W; Mason JW; Wenger T; Jay G; Hebert D; Doty P; Horstmann R
    Acta Neurol Scand; 2015 Nov; 132(5):355-63. PubMed ID: 25933358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gabapentin: new indication. Little impact on partial epilepsy in children between 3 and 12.
    Prescrire Int; 2002 Apr; 11(58):47-8. PubMed ID: 11987312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The efficacy of lacosamide in relation to antiepileptic drug history. Clinical experiences in adult partial epilepsy].
    Barcs Gábor ; Szűcs A; Horváth A; Kamondi A
    Ideggyogy Sz; 2015 Jan; 68(1-2):23-9. PubMed ID: 25842913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epilepsy.
    Marson A; Ramaratnam S
    Clin Evid; 2002 Jun; (7):1153-68. PubMed ID: 12230734
    [No Abstract]   [Full Text] [Related]  

  • 27. Lacosamide: an investigational drug for adjunctive treatment of partial-onset seizures.
    Ben-Menachem E
    Drugs Today (Barc); 2008 Jan; 44(1):35-40. PubMed ID: 18301802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Flunarizine as adjunctive treatment in epilepsy with partial seizures].
    Echevarría GM
    Rev Neurol; 2008 Mar 16-31; 46(6):381-2. PubMed ID: 18368685
    [No Abstract]   [Full Text] [Related]  

  • 29. [Lacosamide (vimpat). Prospects for clinical application].
    Rudakova IG; Vlasov PN; Lipatova LV; Voronkova KV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):147-152. PubMed ID: 29053136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of intravenous lacosamide in refractory nonconvulsive status epilepticus.
    Koubeissi MZ; Mayor CL; Estephan B; Rashid S; Azar NJ
    Acta Neurol Scand; 2011 Feb; 123(2):142-6. PubMed ID: 21198444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effective and 15 years experience. New add-on option in epilepsy therapy]].
    MMW Fortschr Med; 2005 Jun; 147(23):56-7. PubMed ID: 15981910
    [No Abstract]   [Full Text] [Related]  

  • 32. Cost effectiveness of lacosamide in the adjunctive treatment of patients with refractory focal epilepsy in Belgium.
    Simoens S; De Naeyer L; Dedeken P
    CNS Drugs; 2012 Apr; 26(4):337-50. PubMed ID: 22452528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electroencephalographic and Electrocardiographic Effect of Intravenous Lacosamide in Refractory Focal Epilepsy.
    Huang CW; Brown S; Pillay N; Campo MD; Tellez-Zenteno J; McLachlan RS
    J Clin Neurophysiol; 2018 Sep; 35(5):365-369. PubMed ID: 29851686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment protocol for long-term anti-epilepsy drugs in children with refractory epilepsy].
    Dulac O; Chiron C
    Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S265-71. PubMed ID: 15331974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lacosamide use in refractory idiopathic primary generalized epilepsy.
    Zangaladze A; Skidmore C
    Epilepsy Behav; 2012 Jan; 23(1):79-80. PubMed ID: 22197124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Intravenous lacosamide in monotherapy in a case of complex partial epileptic status].
    Granda-Méndez J; Toledo M; Flores-Flores A; Santamarina E; Sarria S; Salas-Puig J
    Rev Neurol; 2011 Jul; 53(1):61-3; authors reply 64. PubMed ID: 21678328
    [No Abstract]   [Full Text] [Related]  

  • 37. Atrioventricular block following lacosamide intoxication.
    Krause LU; Brodowski KO; Kellinghaus C
    Epilepsy Behav; 2011 Apr; 20(4):725-7. PubMed ID: 21411374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defining minimally important change in QOLIE-31 scores: estimates from three placebo-controlled lacosamide trials in patients with partial-onset seizures.
    Borghs S; de la Loge C; Cramer JA
    Epilepsy Behav; 2012 Mar; 23(3):230-4. PubMed ID: 22341962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of epileptic negative myoclonus by addition of lacosamide to carbamazepine.
    Belcastro V; Arnaboldi M; Taborelli A; Prontera P
    Epilepsy Behav; 2011 Mar; 20(3):589-90. PubMed ID: 21367668
    [No Abstract]   [Full Text] [Related]  

  • 40. [Lacosamide in the treatment of epilepsy].
    Petrukhin AS; Voronkova KV; Pylaeva OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(6 Pt 2):65-71. PubMed ID: 22983249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.